Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies.

Wilhelm A, Widera M, Grikscheit K, Toptan T, Schenk B, Pallas C, Metzler M, Kohmer N, Hoehl S, Marschalek R, Herrmann E, Helfritz FA, Wolf T, Goetsch U, Ciesek S

Open source

DOI
10.1016/j.ebiom.2022.104158
Published
2022 Aug
Container
EBioMedicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ebiom.2022.104158,
  title = {Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies.},
  author = {Wilhelm A and Widera M and Grikscheit K and Toptan T and Schenk B and Pallas C and Metzler M and Kohmer N and Hoehl S and Marschalek R and Herrmann E and Helfritz FA and Wolf T and Goetsch U and Ciesek S},
  year = {2022},
  journal = {EBioMedicine},
  doi = {10.1016/j.ebiom.2022.104158},
  url = {https://doi.org/10.1016/j.ebiom.2022.104158}
}

RIS

TY  - JOUR
TI  - Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies.
AU  - Wilhelm A
AU  - Widera M
AU  - Grikscheit K
AU  - Toptan T
AU  - Schenk B
AU  - Pallas C
AU  - Metzler M
AU  - Kohmer N
AU  - Hoehl S
AU  - Marschalek R
AU  - Herrmann E
AU  - Helfritz FA
AU  - Wolf T
AU  - Goetsch U
AU  - Ciesek S
PY  - 2022
JO  - EBioMedicine
DO  - 10.1016/j.ebiom.2022.104158
UR  - https://doi.org/10.1016/j.ebiom.2022.104158
ER  - 

APA

A, W., M, W., K, G., T, T., B, S., C, P., M, M., N, K., S, H., R, M., E, H., FA, H., T, W., U, G., & S, C. (2022). Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies.. EBioMedicine. https://doi.org/10.1016/j.ebiom.2022.104158

Source records